Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In IrelandCurrent recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In GermanyThis study isn't currently recruiting.
Recruitment status comes from the linked ISRCTN record. Both registries list the identifiers for the same study.
In United KingdomThis study isn't currently recruiting.
In NetherlandsAn Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenA Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonThis study evaluated the safety and effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluated the safety and effectiveness of Esketamine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluated the safety and effectiveness of GH001 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Pilsen
This study has finished and is no longer accepting participants.
In Palo AltoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.